A patient with multiple iris by Asselman, V & Meinjes, G
T H E S O U T H E R N A F R I C A N J O U R NA L O F H I V ME D I C I N E                               S P R I N G 2 0 0 7 57
A 38-year-old man from the Democratic Republic of Congo
was diagnosed with disseminated TB on the basis of a sputum
culture which grew Mycobacterium tuberculosis. The isolate
was sensitive to isoniazid and rifampicin. A fine-needle
aspirate of a peripheral lymph node was also positive for acid-
fast bacilli. His chest radiograph from this time is shown in
Fig. 1. The patient was commenced on regimen 1 TB treatment.
An HIV test was reactive and his CD4 count was 9 cells/µl.
Good adherence to TB treatment was reported.
He was referred for ART, but the clinic delayed initiation
because of social problems. Three months later he was re-
admitted with cryptococcal meningitis. Cerebrospinal fluid
(CSF) results are shown in Table II. He received 5 days of
intravenous amphotericin B, followed by oral fluconazole
400 mg daily. His headache and vomiting resolved on this
treatment.
Two weeks after the cryptococcal diagnosis he was started on
ART (stavudine, lamivudine and efavirenz). Fluconazole, TB
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TThe immune reconstitution inflammatory syndrome (IRIS) is a frequent early complication of antiretroviral therapy (ART),
particularly in patients who commence ART with low CD4 counts and established opportunistic infections. IRIS results from a
pathological inflammatory response to pre-existing infective, host or other antigens, alive or dead, causing clinical
deterioration in HIV-infected patients after initiating ART.1 A case definition for IRIS is shown in Table I. The most common
forms of IRIS described occur in association with mycobacterial and herpesvirus infections.3 We describe here a patient who
presented with IRIS in association with tuberculosis (TB), then cryptococcosis, and later varicella zoster virus (VZV).
■ HIV-positive
■ Receiving highly active antiretroviral therapy (HAART)
■ Decrease in HIV-1 RNA level from baseline
■ Increase in CD4+ cells from baseline (may lag behind HIV-
1 RNA decrease)
■ Clinical symptoms consistent with inflammatory process
■ Clinical course not consistent with:
■ Expected course of previously diagnosed opportunistic
infection
■ Expected course of newly diagnosed opportunistic
infection
■ Drug toxicity
TABLE I. CRITERIA FOR DIAGNOSIS OF IRIS PROPOSED BY
SHELBURNE AND COLLEAGUES2
Fig. I. Chest radiograph at the time of TB diagnosis showing
right mediastinal adenopathy with sparse bilateral fine linear
and nodular opacities in the middle and lower zones of the
lungs. 
Timing of LP CM diagnosis CM-IRIS diagnosis
Polymorphs (cells/µl) 1 5
Lymphocytes (cells/µl) 3 45
Erythrocytes (cells/µl) 215 187
Glucose (mmol/l) 2.6 2.8
Protein (g/l) 1.08 1.5
VDRL Negative Negative
Cryptococcal latex >1:4 (not 1:256
antigen test (CLAT) quantified)
Cryptococcus culture Positive Negative
TABLE II. CSF RESULTS AT CM AND CM-IRIS DIAGNOSIS
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treatment and co-trimoxazole were continued. Ten days later
he presented with a 4-day history of severe right-sided
pleuritic chest pain and fevers. No cough or headaches were
reported. He had lost 6 kg in 2 weeks and had a temperature
of 38ºC. Chest auscultation revealed crepitations bibasally. No
lymph node enlargement was detected. Blood oxygen
saturation was normal. The chest radiograph from this time is
shown in Fig. 2. A diagnosis of TB-IRIS was made, but he was
also given antibiotics to cover the possibility of bacterial chest
infection. One week later he reported symptomatic improve-
ment, but still had mild chest pain, a tachycardia and a low-
grade fever.
Four weeks after starting ART he was re-admitted with a 5-day
history of severe headaches and vomiting. He was apyrexial
and had lost 2 kg since his last visit. He had new axillary and
submental adenopathy. Terminal neck stiffness was present
but fundoscopy, visual fields and eye movements were normal.
His CD4 count had risen to 30 cells/µl. A lumbar puncture had
an opening pressure of 56 cm H2O. CSF results are shown in
Table II.
A diagnosis of cryptococcal meningitis IRIS (CM-IRIS) was
made. He was treated with amphotericin B while awaiting a
CSF fungal culture result to exclude treatment failure as a
cause of his symptoms. Prednisone at 1.5 mg/kg for 2 weeks
was added. He also had regular lumbar punctures to decrease
his raised intracranial pressure. His CSF fungal culture was
negative after 2 weeks’ incubation. His symptoms resolved on
this treatment.
Two months after starting ART he developed a VZV rash
involving the left V1 dermatome of his face. The cornea was
not affected. Acyclovir 800 mg 5 times daily was prescribed
and the rash resolved on this treatment.
DISCUSSION
This patient had several of the documented risk factors for
IRIS: opportunistic infections prior to ART, disseminated TB,
low baseline CD4 count and ART initiation soon after CM
diagnosis.4-7
He presented with three episodes of IRIS in the first 2 months
of ART, each related to different infections. Within 2 weeks of
commencing ART the patient was diagnosed with TB-IRIS. This
diagnosis was made on the basis of recurrent respiratory
symptoms and fever, and particularly because the chest
radiograph showed worsening features of TB. TB-IRIS typically
presents 1 - 4 weeks after ART initiation.5,8
The most common manifestations of TB-IRIS are fever and
recurrence of TB symptoms, as in our patient. A wide range of
other manifestations have been described and include
worsening radiographic pulmonary infiltrates, lymph node
enlargement, cold abscesses, serous effusions, hepatic and
splenic involvement and meningitis.9
When this patient presented with TB-IRIS, his chest
radiograph demonstrated bilateral lower zone linear
opacifications and an increase in size of mediastinal lymph
nodes. Radiographic imaging plays an important role in
diagnosing and monitoring TB-IRIS. Radiographically, TB-IRIS
manifests as new or increased pulmonary parenchymal
disease, lymphadenopathy or pleural effusions alone or in
combination. It is not uncommon for patients with advanced
immunosuppression and TB undergoing a TB-IRIS episode
with radiological worsening to have had a normal chest
radiograph at initial TB diagnosis. Conversely, patients
presenting with clinically significant signs and symptoms of
TB-IRIS do not always manifest with radiographic worsening.
In one study the mean time from beginning of radiographic
worsening to beginning of improvement was 7 weeks for
pulmonary disease, 13 weeks for adenopathy, and 4 weeks for
pleural effusions.10
This patient’s presentation with a lymphocytic meningitis 4
weeks after starting ART was diagnosed as CM-IRIS. This is
often associated with raised intracranial pressure, as in this
case, and in one study the median duration from ART to CM-
IRIS was 28 days.7 The finding of a negative fungal culture
excluded cryptococcal treatment failure and supported the
diagnosis of CM-IRIS. The increase in white cell count in the
CSF compared with initial diagnosis, as in this case, was found
to occur in CM-IRIS in the study mentioned above.7 Treatment
of CM-IRIS involves therapeutic lumbar punctures to relieve
raised intracranial pressure and corticosteroids in severe or
refractory cases, although there is no prospective evidence
regarding the management of any form of IRIS.11
His presentation with a VZV rash 2 months after starting ART
was probably also an IRIS event, or could have been related to
the corticosteroid therapy given earlier. Although this was a
typical monodermatomal presentation of this infection, the
finding that patients are at a 5-fold higher risk of presenting
Fig. 2. Chest radiograph at the time of TB-IRIS diagnosis. The
right mediastinal adenopathy is again noted. The pulmonary
infiltrate has become more intense compared with the initial
radiograph. Bilateral mid- and lower zone coarse linear
opacifications with scattered sparse nodules are seen, as well
as foci of confluent irregular opacities up to 1.8 mm in size. A
1.8 cm confluent opacity at the left hemidiaphragm is also
noted.
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with VZV in the first 4 months of ART12 suggests that immune
reconstitution is playing a role in such presentations.
Management is with acyclovir.
Currently IRIS is a diagnosis of exclusion, as there is no
confirmatory test. Important exclusions include treatment
failure due to antimicrobial resistance or poor adherence,
another infection or drug toxicity. A thorough patient history
is important as initial improvement on specific treatment for
an opportunistic infection followed by deterioration after ART
initiation is characteristic of IRIS. IRIS has resource
implications in terms of the increased need for investigations
and treatment interventions, as demonstrated by our patient’s
repeated admissions. This case highlights the risks faced
during immune reconstitution in patients who commence ART
with advanced immunosuppression.
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